DMPK 66に掲載予定の論文一覧
[Review]
Review article
Positive implications of PBPK platform qualification for predicting drug–drug interactions: Taking on cracks only to see bigger gaps!
Amin Rostami-Hodjegan
Review article
Evaluation of OATP1B inhibitory potential using an endogenous biomarker coproporphyrin-I in new drug applications: Case reports submitted by 2024
Ryosuke Watari
Review article
Current status of prediction of IL-6 mediated cytochrome P450 activity modulation using in vitro data and PBPK modeling
Viktor Georgiev, Isabelle Anderka, Delia Bucher, Lena Preiss, … Neil Parrott
Review article
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance
Kenichi Umehara, Andrew Harrell, Chandra Prakash, Constanze Hilgendorf, … Yuan Chen
Review article
Cytochrome P450 reaction phenotyping: State of the art
Elaine Tseng, R. Scott Obach
Review article
The rational use of PBPK to assess the changing DDI liability in pediatrics: Model qualification and the move towards best practice
Trevor N. Johnson, Jean Dinh, Roz Southall, Amin Rostami-Hodjegan
[Regular Articles]
Research article
Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dose toxicity data in rats
Minami Shibata, Nana Uchida, Akira Ooka, Ryota Shizu, Kouichi Yoshinari
[Notes]
Short communication
Analysis of blood-brain barrier permeability of drugs using forensically obtained human cerebrospinal fluid and plasma in Japan
Tomoyoshi Hariba, Kenta Mizoi, Saori Takahashi, Hiroki Sunakawa, … Takuo Ogihara
[Commentary]
Discussion
Role of metabolites in drug-drug interactions
Nina Isoherranen
●各論文のabstractおよび論文内容詳細については，以下のリンクをご覧ください．
Drug Metabolism and Pharmacokinetics | Vol 66, February 2026 | ScienceDirect.com by Elsevier